Healthcare costs associated with Hemodialysis catheter-related infections: A single-center experience

被引:52
作者
Ramanathan, Venkataraman
Chiu, Edwin J.
Thomas, Jim T.
Khan, Ahmad
Dolson, George M.
Darouiche, Rabih O.
机构
[1] MED VA Med Ctr, Renal Sect, Houston, TX 77030 USA
[2] Infect Dis Sect, Houston, TX USA
[3] Baylor Coll Med, Vet Affairs Med Ctr, Houston, TX USA
关键词
D O I
10.1086/513617
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
In patients undergoing hemodialysis, catheter-related bacteremia results in expensive hospitalizations. In our study, the mean cost was $23,451 per hospitalization. When itemized, housing ("bed-related") costs accounted for 66% of the total; laboratory costs accounted for 4%, radiologic costs accounted for 9%, and procedure-related costs accounted for 21%. Hypoalbuminemia and bacteremia due to methicillin-resistant Staphylococcus aureus (MRSA) are associated with higher healthcare costs; bacteremia due to MRSA is also associated with poor survival rates.
引用
收藏
页码:606 / 609
页数:4
相关论文
共 14 条
[1]  
[Anonymous], USRDS 2005 ANN DAT R
[2]   Protein malnutrition and hypoalbuminemia as predictors of vascular events and mortality in ESRD [J].
Cooper, BA ;
Penne, EL ;
Bartlett, LH ;
Pollock, CA .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2004, 43 (01) :61-66
[3]   The impact of methicillin-resistance in Staphylococcus aureus bacteremia on patient outcomes:: Mortality, length of stay, and hospital charges [J].
Cosgrove, SE ;
Qi, YL ;
Kaye, KS ;
Harbarth, S ;
Karchmer, AW ;
Carmeli, Y .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2005, 26 (02) :166-174
[4]  
*DEP HHS, 12 STEPS PREV ANT RE
[5]   Clinical outcomes and costs due to Staphylococcus aureus bacteremia among patients receiving long-term hemodialysis [J].
Engemann, JJ ;
Friedman, JY ;
Reed, SD ;
Griffiths, RI ;
Szczech, LA ;
Kaye, KS ;
Stryjewski, ME ;
Reller, LB ;
Schulman, KA ;
Corey, GR ;
Fowler, VG .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2005, 26 (06) :534-539
[6]   Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection [J].
Engemann, JJ ;
Carmeli, Y ;
Cosgrove, SE ;
Fowler, VG ;
Bronstein, MZ ;
Trivette, SL ;
Briggs, JP ;
Sexton, DJ ;
Kaye, KS .
CLINICAL INFECTIOUS DISEASES, 2003, 36 (05) :592-598
[7]   Revisiting mortality predictability of serum albumin in the dialysis population: time dependency, longitudinal changes and population-attributable fraction [J].
Kalantar-Zadeh, K ;
Kilpatrick, RD ;
Kuwae, N ;
McAllister, CJ ;
Alcorn, H ;
Kopple, JD ;
Greenland, S .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 (09) :1880-1888
[8]   Clinical and economic analysis of methicillin-susceptible and -resistant Staphylococcus aureus infections [J].
Kopp, BJ ;
Nix, DE ;
Armstrong, EP .
ANNALS OF PHARMACOTHERAPY, 2004, 38 (09) :1377-1382
[9]   Clinical and economic outcomes of Staphylococcus aureus septicemia in ESRD patients receiving hemodialysis [J].
Nissenson, AR ;
Dylan, ML ;
Griffiths, RI ;
Yu, HT ;
Dean, BB ;
Danese, MD ;
Dubois, RW .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2005, 46 (02) :301-308
[10]   Mortality risk factors in chronic haemodialysis patients with infective endocarditis [J].
Nori, Uday S. ;
Manoharan, Anup ;
Thornby, John I. ;
Yee, Jerry ;
Parasuraman, Ravi ;
Ramanathan, Venkataraman .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 (08) :2184-2190